LDL phenotype in subjects with mild cognitive impairment and Alzheimer's disease

Sheikh Vikarunnessa, Myron F. Weiner, Gloria Lena Vega

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Centenarians with normal cognitive function have a 'longevity phenotype' characterized by large low-density lipoproteins (LDL) and high-density lipoproteins (HDL) and low incidence of metabolic syndrome, hypertension, and cognitive impairment. Alzheimer's disease (AD) is associated with a number of cardiovascular risk factors, but it is not known if they have or lack the 'longevity phenotype'. Objective: The study was designed to determine LDL size and body fat content and distribution in subjects with mild cognitive impairment (MCI) and AD. Results: Fifty-eight persons with MCI or AD (cases) and 42 control subjects of similar age had measurement of LDL size and lipoprotein lipids after a 12 h fast and analysis of body composition by dual x-ray absorptiometry. Cases had small LDL size more often than controls (73% versus 66%) associated with significantly higher triglycerides, lower HDL cholesterol, and higher triglyceride/HDL cholesterol ratio (p ≤ 0.02). Cases with large LDL had a better lipoprotein profile than those with small LDL. Cases and controls had similar percent body fat, fat index, and lean mass index. Forty-seven percent of cases and 39% of controls were obese. Conclusion: The prevalence of small LDL phenotype in MCI and AD cases contrasts with the 'longevity phenotype' reported for centenarians with preserved cognitive function. The small LDL phenotype is an atherogenic lipoprotein profile found in metabolic syndrome, type 2 diabetes, and insulin resistance. It is now also reported in persons with MCI and AD.

Original languageEnglish (US)
Pages (from-to)571-575
Number of pages5
JournalJournal of Alzheimer's Disease
Volume36
Issue number3
DOIs
StatePublished - 2013

Fingerprint

LDL Lipoproteins
Alzheimer Disease
Phenotype
Lipoproteins
Cognition
HDL Cholesterol
Triglycerides
Body Fat Distribution
Cognitive Dysfunction
HDL Lipoproteins
Body Composition
Type 2 Diabetes Mellitus
Insulin Resistance
Adipose Tissue
Fats
X-Rays
Hypertension
Lipids
Incidence

Keywords

  • Atherogenic dyslipidemia
  • longevity phenotype
  • small LDL

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

LDL phenotype in subjects with mild cognitive impairment and Alzheimer's disease. / Vikarunnessa, Sheikh; Weiner, Myron F.; Vega, Gloria Lena.

In: Journal of Alzheimer's Disease, Vol. 36, No. 3, 2013, p. 571-575.

Research output: Contribution to journalArticle

@article{801241cdd26e40929ce7e06aa447ffb5,
title = "LDL phenotype in subjects with mild cognitive impairment and Alzheimer's disease",
abstract = "Background: Centenarians with normal cognitive function have a 'longevity phenotype' characterized by large low-density lipoproteins (LDL) and high-density lipoproteins (HDL) and low incidence of metabolic syndrome, hypertension, and cognitive impairment. Alzheimer's disease (AD) is associated with a number of cardiovascular risk factors, but it is not known if they have or lack the 'longevity phenotype'. Objective: The study was designed to determine LDL size and body fat content and distribution in subjects with mild cognitive impairment (MCI) and AD. Results: Fifty-eight persons with MCI or AD (cases) and 42 control subjects of similar age had measurement of LDL size and lipoprotein lipids after a 12 h fast and analysis of body composition by dual x-ray absorptiometry. Cases had small LDL size more often than controls (73{\%} versus 66{\%}) associated with significantly higher triglycerides, lower HDL cholesterol, and higher triglyceride/HDL cholesterol ratio (p ≤ 0.02). Cases with large LDL had a better lipoprotein profile than those with small LDL. Cases and controls had similar percent body fat, fat index, and lean mass index. Forty-seven percent of cases and 39{\%} of controls were obese. Conclusion: The prevalence of small LDL phenotype in MCI and AD cases contrasts with the 'longevity phenotype' reported for centenarians with preserved cognitive function. The small LDL phenotype is an atherogenic lipoprotein profile found in metabolic syndrome, type 2 diabetes, and insulin resistance. It is now also reported in persons with MCI and AD.",
keywords = "Atherogenic dyslipidemia, longevity phenotype, small LDL",
author = "Sheikh Vikarunnessa and Weiner, {Myron F.} and Vega, {Gloria Lena}",
year = "2013",
doi = "10.3233/JAD-130443",
language = "English (US)",
volume = "36",
pages = "571--575",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - LDL phenotype in subjects with mild cognitive impairment and Alzheimer's disease

AU - Vikarunnessa, Sheikh

AU - Weiner, Myron F.

AU - Vega, Gloria Lena

PY - 2013

Y1 - 2013

N2 - Background: Centenarians with normal cognitive function have a 'longevity phenotype' characterized by large low-density lipoproteins (LDL) and high-density lipoproteins (HDL) and low incidence of metabolic syndrome, hypertension, and cognitive impairment. Alzheimer's disease (AD) is associated with a number of cardiovascular risk factors, but it is not known if they have or lack the 'longevity phenotype'. Objective: The study was designed to determine LDL size and body fat content and distribution in subjects with mild cognitive impairment (MCI) and AD. Results: Fifty-eight persons with MCI or AD (cases) and 42 control subjects of similar age had measurement of LDL size and lipoprotein lipids after a 12 h fast and analysis of body composition by dual x-ray absorptiometry. Cases had small LDL size more often than controls (73% versus 66%) associated with significantly higher triglycerides, lower HDL cholesterol, and higher triglyceride/HDL cholesterol ratio (p ≤ 0.02). Cases with large LDL had a better lipoprotein profile than those with small LDL. Cases and controls had similar percent body fat, fat index, and lean mass index. Forty-seven percent of cases and 39% of controls were obese. Conclusion: The prevalence of small LDL phenotype in MCI and AD cases contrasts with the 'longevity phenotype' reported for centenarians with preserved cognitive function. The small LDL phenotype is an atherogenic lipoprotein profile found in metabolic syndrome, type 2 diabetes, and insulin resistance. It is now also reported in persons with MCI and AD.

AB - Background: Centenarians with normal cognitive function have a 'longevity phenotype' characterized by large low-density lipoproteins (LDL) and high-density lipoproteins (HDL) and low incidence of metabolic syndrome, hypertension, and cognitive impairment. Alzheimer's disease (AD) is associated with a number of cardiovascular risk factors, but it is not known if they have or lack the 'longevity phenotype'. Objective: The study was designed to determine LDL size and body fat content and distribution in subjects with mild cognitive impairment (MCI) and AD. Results: Fifty-eight persons with MCI or AD (cases) and 42 control subjects of similar age had measurement of LDL size and lipoprotein lipids after a 12 h fast and analysis of body composition by dual x-ray absorptiometry. Cases had small LDL size more often than controls (73% versus 66%) associated with significantly higher triglycerides, lower HDL cholesterol, and higher triglyceride/HDL cholesterol ratio (p ≤ 0.02). Cases with large LDL had a better lipoprotein profile than those with small LDL. Cases and controls had similar percent body fat, fat index, and lean mass index. Forty-seven percent of cases and 39% of controls were obese. Conclusion: The prevalence of small LDL phenotype in MCI and AD cases contrasts with the 'longevity phenotype' reported for centenarians with preserved cognitive function. The small LDL phenotype is an atherogenic lipoprotein profile found in metabolic syndrome, type 2 diabetes, and insulin resistance. It is now also reported in persons with MCI and AD.

KW - Atherogenic dyslipidemia

KW - longevity phenotype

KW - small LDL

UR - http://www.scopus.com/inward/record.url?scp=84881423555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881423555&partnerID=8YFLogxK

U2 - 10.3233/JAD-130443

DO - 10.3233/JAD-130443

M3 - Article

VL - 36

SP - 571

EP - 575

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 3

ER -